No Data
US Stock MarketDetailed Quotes
TRUMF TERUMO CORP
Watchlist
32.476
+1.018+3.24% Close 11/27 16:00 ET
32.508High31.392Low5.56KVolume
31.392Open31.458Pre Close180.14KTurnover0.00%Turnover Ratio36.53P/E (TTM)24.19BMarket Cap33.57052wk High36.29P/E (Static)744.71MShares24.96452wk Low2.85P/B24.19BFloat Cap50.000Historical High0.29Dividend TTM744.71MShs Float24.964Historical Low0.89%Div YieldTTM3.55%Amplitude32.411Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About TERUMO CORP Company
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Revenue Breakdown
Business
Unit:JPY
2023/03/31
Stock NameRevenueRatio
Cardiovascular Company480.61B58.60%
Medical Care Solutions Company191.75B23.38%
Blood and Cell Technology Company147.61B18.00%
Adjustment amount243M0.03%
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--